EUVIMEDEUVIMED entdecken
Open Access

Intravitreal Adalimumab in Retinitis Pigmentosa: A Prospective Pilot Study Assessing Ocular Safety and Feasibility

Rubens C Siqueira, Tainara S Pinho, Cinara C Brandao

Cureus · 18.05.2026

DOI: 10.7759/cureus.109091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 18.05.2026. Verfasst von Rubens C Siqueira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Department, Faculdade de Medicina de São José do Rio Preto, Sao Jose do Rio Preto, BRA. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ellipsoid zoneergintravitreal adalimumaboctpilot studyretinitis pigmentosavisual field

Autor:innen und Institutionen

  • Postgraduate Department, Faculdade de Medicina de São José do Rio Preto, Sao Jose do Rio Preto, BRA.
  • Immunogenetics Laboratory, Department of Dermatological, Infectious, and Parasitic Diseases, Faculdade de Medicina de São José do Rio Preto, Sao Jose do Rio Preto, BRA.

Zitieren

APA

Siqueira, R. C., Pinho, T. S., & Brandao, C. C. (2026). Intravitreal Adalimumab in Retinitis Pigmentosa: A Prospective Pilot Study Assessing Ocular Safety and Feasibility. Cureus. https://doi.org/10.7759/cureus.109091

Vancouver

Siqueira RC, Pinho TS, Brandao CC. Intravitreal Adalimumab in Retinitis Pigmentosa: A Prospective Pilot Study Assessing Ocular Safety and Feasibility. Cureus. 2026. doi:10.7759/cureus.109091

BibTeX
@article{Siqueira2026,
  author = {Siqueira, Rubens C and Pinho, Tainara S and Brandao, Cinara C},
  title = {Intravitreal Adalimumab in Retinitis Pigmentosa: A Prospective Pilot Study Assessing Ocular Safety and Feasibility},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.109091}
}
Kostenlos starten →